Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis

Upadacitinib in refractory acquired reactive perforating collagenosis with atopic dermatitis and chronic kidney disease: a case report.
Qing Wang, Maolin Yao, Lvyao Wang +5
Frontiers in medicine7 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Rituximab Combined With Azathioprine for Relapsed Anti-MDA5 Antibody-Positive Dermatomyositis With Interstitial Lung Disease: A Case Report.
Hiroki Ozaki, Yuki Inoue
Case reports in rheumatology21 Oct 2026Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
Staged multi-target therapy for anti-MDA5-positive dermatomyositis-associated rapidly progressive interstitial lung disease: a case report.
Lvdan Zhang, Mengwen Jiao, Yan Hou +5
Respiratory medicine case reports29 Sep 2026Peer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMC
Candidate molecular endotypes and dynamic risk prediction in anti-MDA5-positive dermatomyositis-associated interstitial lung disease: a systematic scoping review
Zhiwei Zuo, Jianguo Yang, Jianbin Li +2
Frontiers in Immunology9 Oct 2026Peer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
OA26 Anti-NXP2-Positive Juvenile Dermatomyositis in an Adolescent Following a Five-Year History of Childhood Cutaneous Manifestations, Presenting with Severe Myositis, Bulbar Weakness and Respiratory Failure Complicated by Macrophage Activation Syndrome
Md Shahriar Kabir, Maira Karabayas, Paula Dospinescu
Rheumatology advances in practice1 Nov 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCPMC

Cite

BibTeX

@article{demir2026upadacitinib,
  title = {{Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis}},
  author = {Yusuf Demir and Hande Ogun and Bercemhan Sulu and Muazzez Cigdem Oba and Emire Seyahi},
  journal = {Anais Brasileiros de Dermatologia},
  year = {2026},
  month = oct,
  doi = {10.1016/j.abd.2026.501443},
  url = {https://doi.org/10.1016/j.abd.2026.501443},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis
AU  - Yusuf Demir
AU  - Hande Ogun
AU  - Bercemhan Sulu
AU  - Muazzez Cigdem Oba
AU  - Emire Seyahi
PY  - 2026
DA  - 2026/10/01
JO  - Anais Brasileiros de Dermatologia
DO  - 10.1016/j.abd.2026.501443
UR  - https://doi.org/10.1016/j.abd.2026.501443
SN  - 0365-0596
ER  -

Related

Cite